AEGEA Medical raises $36 mln
AEGEA Medical Inc. said Monday that it closed its Series C financing of $36 million with investments from existing investors Alloy Ventures, Delphi Ventures and Covidien/Medtronic. New major investors included BioMed Ventures and Solas Bioventures. Redwood City, California-based AEGEA is developing technology to treat menorrhagia.
4 May 2015•2 mins read
